Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Association of SNPs of CD40 Gene with Multiple Sclerosis in Russians.
[Neuropsychological assessment of patients with relapsing remitting multiple sclerosis prior to the use of immunomodulatory drugs].
Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients.
[Impact of physical activity level on alexithymia and coping strategies in an over-40 multiple sclerosis population: A pilot study.]
Case of Type 1 Diabetes Mellitus Following Interferon β-1a Treatment for Multiple Sclerosis.
Pregnancy and multiple sclerosis.
Monoclonal antibody therapies for the treatment of relapsing-remitting multiple sclerosis: differentiating mechanisms and clinical outcomes.
NDRG2 promoted secreted miR-375 in microvesicles shed from M1 microglia, which induced neuron damage.
Spinal Cord Normalization in Multiple Sclerosis.
Tissue Transglutaminase in Marmoset Experimental Multiple Sclerosis: Discrepancy between White and Grey Matter.
Massive exacerbation of multiple sclerosis after withdrawal and early restart of treatment with natalizumab.
TRPM2 Cation Channels Modulate T Cell Effector Functions and Contribute to Autoimmune CNS Inflammation.
[Therapy adherence to immunomodulator treatment in patients with multiple sclerosis].
No evidence for a role of rare CYP27B1 functional variations in multiple sclerosis.
Neuromuscular adaptations to long-term progressive resistance training translates to improved functional capacity for people with multiple sclerosis and is maintained at follow-up.
Multiple sclerosis risk loci correlate with cervical cord atrophy and may explain the course of disability.
Utilization and patients' perceptions of the effectiveness of pain treatments in multiple sclerosis: A cross-sectional survey.
Jugular Venous Flow Abnormalities in Multiple Sclerosis Patients Compared to Normal Controls.
The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases.
Genetic associations with brain cortical thickness in multiple sclerosis.
The human papillomavirus vaccination is not associated with risk of multiple sclerosis or other demyelinating diseases.
Emerging role of long noncoding RNAs in autoimmune diseases.
Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease.
[Local reactions to disease-modifying drugs: pathogenesis and relationship to clinical effectiveness.]
Axon-glia interaction and membrane traffic in myelin formation.
Pages
« first
‹ previous
…
391
392
393
394
395
396
397
398
399
…
next ›
last »